132 related articles for article (PubMed ID: 36882195)
1. Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia.
Pincez T; Fernandes H; Pasquet M; Abou Chahla W; Granel J; Héritier S; Fahd M; Ducassou S; Thomas C; Garnier N; Barlogis V; Jeziorski E; Bayart S; Chastagner P; Cheikh N; Guitton C; Paillard C; Lejeune J; Millot F; Li-Thiao Te V; Mallebranche C; Pellier I; Neven B; Armari-Alla C; Carausu L; Piguet C; Benadiba J; Pluchart C; Stephan JL; Deparis M; Briandet C; Doré E; Marie-Cardine A; Leblanc T; Leverger G; Aladjidi N
Am J Hematol; 2023 Jun; 98(6):857-868. PubMed ID: 36882195
[TBL] [Abstract][Full Text] [Related]
2. Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome.
Pincez T; Fernandes H; Fahd M; Pasquet M; Chahla WA; Granel J; Ducassou S; Thomas C; Garnier N; Jeziorski E; Bayart S; Chastagner P; Cheikh N; Guitton C; Paillard C; Lejeune J; Millot F; Li-Thiao Te V; Mallebranche C; Pellier I; Castelle M; Armari-Alla C; Carausu L; Piguet C; Benadiba J; Pluchart C; Stephan JL; Deparis M; Briandet C; Doré E; Marie-Cardine A; Barlogis V; Leverger G; Héritier S; Aladjidi N; Leblanc T
Am J Hematol; 2024 Jul; 99(7):1269-1280. PubMed ID: 38651646
[TBL] [Abstract][Full Text] [Related]
3. Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years.
Ducassou S; Gourdonneau A; Fernandes H; Leverger G; Pasquet M; Fouyssac F; Bayart S; Bertrand Y; Michel G; Jeziorski E; Thomas C; Abouchallah W; Viard F; Guitton C; Cheikh N; Pellier I; Carausu L; Droz C; Leblanc T; Aladjidi N;
Br J Haematol; 2020 Jun; 189(5):931-942. PubMed ID: 32130726
[TBL] [Abstract][Full Text] [Related]
4. Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children.
Song Y; Zhang Y; Li Z; Liu J; Xiao J; Song H
Ann Hematol; 2022 Jul; 101(7):1447-1456. PubMed ID: 35532821
[TBL] [Abstract][Full Text] [Related]
5. Management of chronic immune thrombocytopenia in children and adolescents: lessons from an Austrian national cross-sectional study of 81 patients.
Sipurzynski J; Fahrner B; Kerbl R; Crazzolara R; Jones N; Ebetsberger G; Jauk B; Strenger V; Wohlmuther B; Schwinger W; Lackner H; Urban C; Holter W; Minkov M; Kager L; Benesch M; Seidel MG
Semin Hematol; 2016 Apr; 53 Suppl 1():S43-7. PubMed ID: 27312164
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Arthritis Res Ther; 2022 Sep; 24(1):213. PubMed ID: 36068638
[TBL] [Abstract][Full Text] [Related]
7. Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden.
Pincez T; Fernandes H; Leblanc T; Michel G; Barlogis V; Bertrand Y; Neven B; Chahla WA; Pasquet M; Guitton C; Marie-Cardine A; Pellier I; Armari-Alla C; Benadiba J; Blouin P; Jeziorski E; Millot F; Paillard C; Thomas C; Cheikh N; Bayart S; Fouyssac F; Piguet C; Deparis M; Briandet C; Dore E; Picard C; Rieux-Laucat F; Landman-Parker J; Leverger G; Aladjidi N
Haematologica; 2022 Feb; 107(2):457-466. PubMed ID: 33440924
[TBL] [Abstract][Full Text] [Related]
8. Variables related to chronic immune thrombocytopenia: experience from a single center and comparison to a meta-analysis.
Fernández-Plaza S; González de Pablo J; Gálvez E; Zubicaray J; Guillén M; Sevilla J; Sebastián E
Eur J Pediatr; 2021 Jul; 180(7):2075-2081. PubMed ID: 33594540
[TBL] [Abstract][Full Text] [Related]
9. Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: Prevalence and risk factors.
Kittivisuit S; Vachvanichsanong P; McNeil E; Chotsampancharoen T
Pediatr Blood Cancer; 2021 Aug; 68(8):e29146. PubMed ID: 34047041
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis.
Zhou EM; Shen H; Wang D; Xu W
PeerJ; 2024; 12():e17152. PubMed ID: 38666084
[TBL] [Abstract][Full Text] [Related]
11. Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias.
Pincez T; Aladjidi N; Héritier S; Garnier N; Fahd M; Abou Chahla W; Fernandes H; Dichamp C; Ducassou S; Pasquet M; Bayart S; Moshous D; Cheikh N; Paillard C; Plantaz D; Jeziorski E; Thomas C; Guitton C; Deparis M; Marie Cardine A; Stephan JL; Pellier I; Doré E; Benadiba J; Pluchart C; Briandet C; Barlogis V; Leverger G; Leblanc T
Blood; 2022 Jul; 140(3):253-261. PubMed ID: 35443028
[TBL] [Abstract][Full Text] [Related]
12. Routine clinical care for chronic immune thrombocytopenia purpura in Denmark, 2009-2015.
Ording AG; Kristensen NR; Frederiksen H; Alam N; Bahmanyar S; Ghanima W; Nørgaard M; Christiansen CF
Hematology; 2019 Dec; 24(1):732-736. PubMed ID: 31674882
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic thrombocytopenic purpura as first manifestation of systemic lupus erythematosus lupus].
Balsalobre Aznar J; Herráez Herrera P; Porta Etessam J; Torres Martín C; Bermell Serrano JC; Núñez López R; Mateo Bernardo I; Padrino Martínez JM; Morillas López L
An Med Interna; 1999 Dec; 16(12):611-4. PubMed ID: 10686711
[TBL] [Abstract][Full Text] [Related]
15. Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients.
Roussotte M; Gerfaud-Valentin M; Hot A; Audia S; Bonnotte B; Thibault T; Lobbes H; Le Guenno G; Goulabchand R; Cathebras P; Varron L; Dufour JF; Deroux A; Compain C; Baudet A; Karkowski L; Pérard L; Ebbo M; Lega JC; Sève P
Rheumatology (Oxford); 2022 Aug; 61(9):3627-3639. PubMed ID: 34918048
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
Abe K; Ishikawa Y; Ishikawa J; Fujiwara M; Kita Y
Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
[TBL] [Abstract][Full Text] [Related]
17. Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.
Maroun MC; Ososki R; Andersen JC; Dhar JP
Lupus; 2015 Jun; 24(7):746-50. PubMed ID: 25416695
[TBL] [Abstract][Full Text] [Related]
18. Increased proportion of Th17/Treg cells at the new diagnosed stage of chronic immune thrombocytopenia in pediatrics: the pilot study from a multi-center.
Gu H; Chen Z; Shi X; Cui H; Qin X; Hu H; Ma J; Fu L; Ma J; Wang T; Wu R
Eur J Pediatr; 2021 Nov; 180(11):3411-3417. PubMed ID: 34046719
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.
Khellaf M; Chabrol A; Mahevas M; Roudot-Thoraval F; Limal N; Languille L; Bierling P; Michel M; Godeau B
Am J Hematol; 2014 Feb; 89(2):194-8. PubMed ID: 24254965
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial.
Brito HS; Braga JA; Loggetto SR; Machado RS; Granato CF; Kawakami E
Platelets; 2015; 26(4):336-41. PubMed ID: 24832381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
